Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

284
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
284
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

274
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
274
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

288
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
288
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

386
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
386
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

261
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
261
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

963
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
963

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Transformer-DAPT: AI-based dynamic assessment of ischemic and bleeding risks in patients on DAPT following PCI.

NPJ digital medicine·2026
Same author

RLBWT-based LCP computation in compressed space for terabase-scale pangenome analysis.

Bioinformatics (Oxford, England)·2026
Same author

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same author

Vision transformer autoencoders captures local and non-local features in brain imaging to reveal novel genetic associations.

Communications biology·2026
Same author

Replicability of unsupervised deep learning derived image phenotypes.

bioRxiv : the preprint server for biology·2026
Same author

Genetic architecture of white matter microstructure captured by unsupervised deep representation learning of fractional anisotropy maps.

Nature communications·2026

関連する実験動画

Updated: Feb 24, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.9K

バンコマイシン投与戦略評価のための強化学習(RL)動機付けシミュレーションフレームワーク

Bingyu Mao1, Ziqian Xie1, Laila Rasmy1

  • 1McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, United States.

AMIA ... Annual Symposium proceedings. AMIA Symposium
|February 23, 2026
PubMed
まとめ

バンコマイシンの投与量最適化は、患者の転帰にとって重要です。深層学習と強化学習(RL)を使用した新しいシミュレーションフレームワークは、バンコマイシン療法の最適な投与戦略を決定するのに役立ちます。

キーワード:
バンコマイシン投与量強化学習シミュレーション薬物動態深層学習治療成果

さらに関連する動画

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.7K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K

関連する実験動画

Last Updated: Feb 24, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.9K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.7K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K

科学分野:

  • 薬物動態学と薬力学
  • 計算生物学
  • 医療における機械学習

背景:

  • 治療効果を高め、毒性を最小限に抑えるためには、治療域のバンコマイシンレベルを達成し維持することが重要です。
  • 既存のバンコマイシン投与ガイドラインは経験的データに基づいています が、多様な条件下での最適な理論的戦略は完全には理解されていません。

研究 の 目的:

  • バンコマイシン投与戦略の最適化のための新しい強化学習(RL)ベースのシミュレーションフレームワークを開発すること。
  • 面積の時間濃度曲線(AUC)を使用して、臨床ガイドラインをRL報酬システムに統合すること。

主な方法:

  • 深層学習による2コンパートメント薬物動態モデル(PK-RNN-2CM)を開発しました。
  • 患者固有のデータを使用して、真の濃度時間曲線(ground truth time-concentration curves)を生成しました。
  • 実世界のばらつきを模倣するためにノイズ摂動を含むさまざまな条件下でバンコマイシン投与戦略をシミュレートしました。
  • 評価指標として24時間AUCと二乗平均平方根誤差(RMSE)を使用しました。

主要な成果:

  • ノイズのないシミュレーションでは、低投与量と高投与量の両方のAUCターゲットで同等のパフォーマンスが示されました。
  • 低投与量戦略は、ノイズの多い条件下でより高いAUC報酬スコアを達成しました。
  • 高投与量戦略は、ノイズの多い条件下でより大きな安定性を示しました。

結論:

  • 開発されたRLベースのシミュレーションフレームワークは、バンコマイシン投与量の最適化のための新しいアプローチを提供します。
  • この方法論は、バンコマイシン療法における患者の転帰を改善するための投与戦略の洗練に役立ちます。
  • 臨床ガイドラインを組み込み、実世界のばらつきをシミュレートするフレームワークの能力は、治療薬物モニタリングに貴重な洞察を提供します。